+ All Categories
Home > Documents > Psicofarmaci e disturbi cognitivi · 2009-10-27 · Akatisia/agitation compulsions SEROTONERGIC...

Psicofarmaci e disturbi cognitivi · 2009-10-27 · Akatisia/agitation compulsions SEROTONERGIC...

Date post: 08-Jan-2020
Category:
Upload: others
View: 0 times
Download: 0 times
Share this document with a friend
10
Psicofarmaci e disturbi cognitivi Mar Mario Amore Dipartimento di Neuroscienze Università di Parma Parma, 23 ottobre 2009 Given that depot antipsychotics can reduce the time spent in hospital, they should also be expected to reduce costs. In a pharmacoeconomic model of costs associated with depot medication in ‘revolving door’ patients (i.e. those needing frequent rehospitalization), the total direct treatment cost for a patient receiving a conventional oral antipsychotic was estimated to be US$5752. Switching the patient to a depot antipsychotic reduced this cost to $4595. In a 24-week naturalistic study of patients attending an out-patient clinic in Moscow followed by an analytical study of the same patient cohort over a hypothetical 5-year period, economic analysis showed that there was a 50% saving in total direct costs with depot medication, despite the higher acquisition costs. 1
Transcript
Page 1: Psicofarmaci e disturbi cognitivi · 2009-10-27 · Akatisia/agitation compulsions SEROTONERGIC PATHWAYS First of all, the term “neurotrasnmitter”, used for serotonin, norepinephrine,

Psicofarmaci e disturbi cognitivi

MarMario AmoreDipartimento di Neuroscienze

Università di Parma

Parma, 23 ottobre 2009

Given that depot antipsychotics can reduce the time spent in hospital, they should also be expected to reduce costs. In a pharmacoeconomic model of costs associated with depot medication in ‘revolving door’ patients (i.e. those needing frequent rehospitalization), the total direct treatment cost for a patient receiving a conventional oral antipsychotic was estimated to be US$5752. Switching the patient to a depot antipsychotic reduced this cost to $4595. In a 24-week naturalistic study of patients attending an out-patient clinic in Moscow followed by an analytical study of the same patient cohort over a hypothetical 5-year period, economic analysis showed that there was a 50% saving in total direct costs with depot medication, despite the higher acquisition costs.

1

Page 2: Psicofarmaci e disturbi cognitivi · 2009-10-27 · Akatisia/agitation compulsions SEROTONERGIC PATHWAYS First of all, the term “neurotrasnmitter”, used for serotonin, norepinephrine,

1

Mood depression

Mood depression

In this way the pathogenesis of mood depression is to be considered

not only related to a cerebral neurotransmission imbalance, but also to other CNS modifications (such as neurotrophic,

neurosteroidal, hormonal alterations) and diffuse somatic changes (related to autonomic, immunological,

metabolic systems).

2

Page 3: Psicofarmaci e disturbi cognitivi · 2009-10-27 · Akatisia/agitation compulsions SEROTONERGIC PATHWAYS First of all, the term “neurotrasnmitter”, used for serotonin, norepinephrine,

2

Locus coeruleus

mood

Frontal cortex

cognition

limbic

driveagitationemotivity cerebellum

tremors

heartheart

tachycardiatachycardiabladderbladder

urinaryurinary hesitancyhesitancy

stemstem and and vesselsvessels

bloodblood pressionpression

NORADRENERGIC PATHWAYSNORADRENERGIC PATHWAYS

The same considerations have to be applied to all other somaticmanifestations,

particularly for noradrenergic antidepressants.

Noradrenergic system is actually linked to stress stimuli.

In depressed patients the reduced function of noradrenergicneurons

is related to the individual hypersensitivity to environmentalstressors

that causes an inadequate behavioural and somatic responce tostress

3

Page 4: Psicofarmaci e disturbi cognitivi · 2009-10-27 · Akatisia/agitation compulsions SEROTONERGIC PATHWAYS First of all, the term “neurotrasnmitter”, used for serotonin, norepinephrine,

3

rostralrostral rapheraphe nucleinuclei

caudal caudal rapheraphenucleinuclei

NeocortexNeocortex

HypothalamusHypothalamus

MedullaMedulla

HyppocampusHyppocampus

Limbic areasLimbic areas

BasalBasal GangliaGanglia

sexualsexual and and eatingeatingbehaviourbehaviour

BrainBrain stemstemsleepsleep,nausea, ,nausea, vomitvomit

orgasmorgasmpainpain

VesselsVesselsvasoconstrictionvasoconstrictionvasodilatationvasodilatation motilitymotility

GutGut

moodmood

anxietyanxiety

panicpanic

moodmood

AkatisiaAkatisia//agitationagitationcompulsionscompulsions

SEROTONERGIC PATHWAYS

First of all, the term “neurotrasnmitter”, used for serotonin, norepinephrine, dopamine and so forth,

is conceptually wrong

because these are “transmitters” (not only “neuro”) acting on the whole body

with a diffuse somatic responce to the antidepressant treatment.

When we use an AD we can’t consider the vasal responce as a side effect

because it is a component of the antidepressant activity.

4

Page 5: Psicofarmaci e disturbi cognitivi · 2009-10-27 · Akatisia/agitation compulsions SEROTONERGIC PATHWAYS First of all, the term “neurotrasnmitter”, used for serotonin, norepinephrine,

Boadie W. Dunlop, MD;Charles B. Nemeroff, MD, PhD ARCH GEN PSYCHIATRY/VOL 64, MAR 2007

45

Page 6: Psicofarmaci e disturbi cognitivi · 2009-10-27 · Akatisia/agitation compulsions SEROTONERGIC PATHWAYS First of all, the term “neurotrasnmitter”, used for serotonin, norepinephrine,

SRI

NRI

SNRISRI

NRIM1

H1

TCA

1950-6019501950--6060 1970-8019701970--8080 >1990>1990>1990

SRI

SSRI

Criteria of choice: Efficacy & Tolerability

Evolution of ADs in Treatment of Depression

6

Page 7: Psicofarmaci e disturbi cognitivi · 2009-10-27 · Akatisia/agitation compulsions SEROTONERGIC PATHWAYS First of all, the term “neurotrasnmitter”, used for serotonin, norepinephrine,

Escitalopram – SSRI

Agomelatine – MT agonist / 5HT2Cantagonist

Selegiline patch – transdermalMAOI

Gepirone – 5HT1A agonist

NK-1 antagonists

CRF antagonists

Bupropion metabolite

Venlafaxine metabolite

Vagal nerve stimulation (VNS)Repetitive transcranial magnetic stimulationDeep brain stimulation

7

Page 8: Psicofarmaci e disturbi cognitivi · 2009-10-27 · Akatisia/agitation compulsions SEROTONERGIC PATHWAYS First of all, the term “neurotrasnmitter”, used for serotonin, norepinephrine,

Normal status

Neurotransm

neurotransm. depletion

Neurotransm

Up - regulation Down - regulation

reuptake inhibition

Neurotransm

Antidepressan

8

Page 9: Psicofarmaci e disturbi cognitivi · 2009-10-27 · Akatisia/agitation compulsions SEROTONERGIC PATHWAYS First of all, the term “neurotrasnmitter”, used for serotonin, norepinephrine,

8

nucleusnucleus

ReceptorReceptor

Protein Protein kinasekinase

effettoreeffettore

BDNF & others targets

Ó function and neuronalsurviving abilitySinaptic remodelingStructural plasticityNT NT releaserelease controlcontrol

ReceptorReceptor expressionexpressioncontrolcontrol

CytoplasmaticCytoplasmatictransduction controltransduction control

Gene expression controlGene expression control

Antidepressants EffectsAntidepressants Effectsafter chronic after chronic somministrationsomministration

Le alterazioni osservate dopo trattamento con antidepressivi indicano inequivocabilmente un effetto regolatorio sui sistemi serotoninergici e adrenergici, che comprendono, oltre alle azioni sui recettori, anche un aumento della quantità del secondo messaggero cAMP, pur in presenza di un ridotto numero di recettori beta-adrenergici, e la conseguente attivazione di sistemi enzimatici che possono regolare la funzione cellulare attraverso la fosforilazione di specifiche proteine. Grazie anche all’affinarsi delle tecniche di indagine neurochimica, è stato osservato che un trattamento prolungato con farmaci antidepressivi è in grado di potenziare il processo della fosforilazione proteica mediata dalla proteino-kinasi cAMP dipendente di tipo II (PKA). Una delle proteine fosforilate dalla PK cAMP-dipendente è il fattore di trascrizione CREB (cAMP response element-binding protein) che media molte azioni intracellulari del cAMP a livello dell’espressione genica. Il fattore di trascrizione nucleare CREB è stato proposto come target postrecettoriale candidato a mediare le risposte adattative che si verificherebbero in seguito a trattamento prolungato con diverse classi di farmaci antidepressivi. Questo anche sulla base del fatto che CREB risulta essere regolato sia da 5-HT che da NA, neurotrasmettitori sicuramente coinvolti nella fisiopatologia e terapia della depressione.

9

Page 10: Psicofarmaci e disturbi cognitivi · 2009-10-27 · Akatisia/agitation compulsions SEROTONERGIC PATHWAYS First of all, the term “neurotrasnmitter”, used for serotonin, norepinephrine,

9

More recently some studies investigate the effect of antidepressantson hippocampal neurogenesis in the adult rat,using the thymidine analog bromodeoxyuridine (BrdU) as a marker for dividing cells.

10


Recommended